Prof. Dr. KAZIM YAL&#199;IN ARGA

Virology , cilt.582, ss.90-99, 2023 (SCI-Expanded) Sürdürülebilir Kalkınma

20. Systems Biomarkers, Artificial Intelligence, and One Health Vision Can Help Fight Antimicrobial Resistance

KULA C., ARĞA K. Y.

OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY , cilt.27, sa.4, ss.191-192, 2023 (SCI-Expanded)

21. A Transcriptomic and Reverse-Engineering Strategy Reveals Molecular Signatures of Arachidonic Acid Metabolism in 12 Cancers

KUBAT ÖKTEM E., Aydin B., Gulfidan G., ARĞA K. Y.

OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY , cilt.27, sa.3, ss.127-138, 2023 (SCI-Expanded) Sürdürülebilir Kalkınma

22. Potential Early Markers for Breast Cancer: A Proteomic Approach Comparing Saliva and Serum Samples in a Pilot Study

Sinha I., Fogle R. L., Gulfidan G., Stanley A. E., Walter V., Hollenbeak C. S., et al.

International Journal of Molecular Sciences , cilt.24, sa.4, 2023 (SCI-Expanded)

23. Editorial: Omics integration and network medicine to decipher human complex diseases

Zanfardino M., Babbi G., ARĞA K. Y., Pane K.

Frontiers in Genetics , cilt.14, 2023 (SCI-Expanded)

24. Integrative Analysis of Motor Neuron and Microglial Transcriptomes from SOD1(G93A) Mice Models Uncover Potential Drug Treatments for ALS

KUBAT ÖKTEM E., Aydin B., Yazar M., ARĞA K. Y.

JOURNAL OF MOLECULAR NEUROSCIENCE , cilt.72, sa.11, ss.2360-2376, 2022 (SCI-Expanded)

25. Human oncogenic viruses: an overview of protein biomarkers in viral cancers and their potential use in clinics

EXPERT REVIEW OF ANTICANCER THERAPY , cilt.22, sa.11, ss.1211-1224, 2022 (SCI-Expanded) Sürdürülebilir Kalkınma

26. A Pan-Cancer Atlas of Differentially Interacting Hallmarks of Cancer Proteins

Kori M., Ozdemir G. E., ARĞA K. Y., Sinha R.

JOURNAL OF PERSONALIZED MEDICINE , cilt.12, sa.11, 2022 (SCI-Expanded)

27. Precision Oncology: An Ensembled Machine Learning Approach to Identify a Candidate mRNA Panel for Stratification of Patients with Breast Cancer

Kurt F., AĞAOĞLU M., ARĞA K. Y.

OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY , cilt.26, ss.504-511, 2022 (SCI-Expanded)

28. Acute Myeloid Leukemia: New Multiomics Molecular Signatures and Implications for Systems Medicine Diagnostics and Therapeutics Innovation

Kelesoglu N., Kori M., TURANLI B., ARĞA K. Y., Yilmaz B., Duru O. A.

OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY , cilt.26, sa.7, ss.392-403, 2022 (SCI-Expanded) Sürdürülebilir Kalkınma

29. Repositioning of Anti-Inflammatory Drugs for the Treatment of Cervical Cancer Sub-Types

Kori M., ARĞA K. Y., Mardinoglu A., TURANLI B.

FRONTIERS IN PHARMACOLOGY , cilt.13, 2022 (SCI-Expanded)

30. Driving Precision Oncology to Clinical Practice: The Road Ahead from Biomarker Validation to Clinical Decision Systems

Yilmaz B., ARĞA K. Y.

OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY , cilt.26, sa.6, ss.358-359, 2022 (SCI-Expanded)

31. Multiomics Data Integration Identifies New Molecular Signatures for Abdominal Aortic Aneurysm and Aortic Occlusive Disease: Implications for Early Diagnosis, Prognosis, and Therapeutic Targets

Kori M., Cig D., Arga K. Y., Kasavi C.

OMICS A JOURNAL OF INTEGRATIVE BIOLOGY , cilt.26, sa.5, ss.1-15, 2022 (SCI-Expanded)

32. Precision Diagnosis of Maturity-Onset Diabetes of the Young with Next-Generation Sequencing: Findings from the MODY-IST Study in Adult Patients

Aydogan H. Y., Gul N., Demirci D. K., Mutlu U., Gulfidan G., ARĞA K. Y., et al.

OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY , cilt.26, ss.218-235, 2022 (SCI-Expanded) Sürdürülebilir Kalkınma

33. Past, Present, and Future of Therapies for Pituitary Neuroendocrine Tumors: Need for Omics and Drug Repositioning Guidance

Aydin B., Yildirim E., ERDOĞAN O., ARĞA K. Y., Yilmaz B., BOZKURT S., et al.

OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY , cilt.26, sa.3, ss.115-129, 2022 (SCI-Expanded) Sürdürülebilir Kalkınma

34. MicroRNA-Mediated Drug Repurposing Unveiled Potential Candidate Drugs for Prolactinoma Treatment

Aydin B., Arslan S., BAYRAKLI F., YILMAZ B., ARĞA K. Y.

NEUROENDOCRINOLOGY , cilt.112, ss.161-173, 2022 (SCI-Expanded)

35. Systems biomarkers for papillary thyroid cancer prognosis and treatment through multi-omics networks

Gulfidan G., Soylu M., Demirel D., Erdonmez H. B. C., Beklen H., ÖZBEK SARICA P., et al.

ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS , cilt.715, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

36. Decreased serum levels of glycerol-3-phosphate dehydrogenase 1 and monoacylglycerol lipase act as diagnostic biomarkers for breast cancer

KARAOSMANOĞLU YÖNETEN K., KASAP M., ARĞA K. Y., AKPINAR G., UTKAN N. Z.

CANCER BIOMARKERS , cilt.34, sa.1, ss.67-76, 2022 (SCI-Expanded) Sürdürülebilir Kalkınma

37. Artificial Intelligence as Accelerator for Genomic Medicine and Planetary Health

Gulfidan G., Beklen H., ARĞA K. Y.

OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY , cilt.25, ss.745-749, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma

38. Lower COVID-19 Mortality in Patients with Type 2 Diabetes Mellitus Taking Dipeptidyl Peptidase-4 Inhibitors: Results from a Turkish Nationwide Study

Emral R., Haymana C., Demirci I., Tasci I., Sahin M., Cakal E., et al.

DIABETES THERAPY , cilt.12, sa.11, ss.2857-2870, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma

39. Differential Interactome Based Drug Repositioning Unraveled Abacavir, Exemestane, Nortriptyline Hydrochloride, and Tolcapone as Potential Therapeutics for Colorectal Cancers

beklen h., arslan s., Gulfidan G., Turanlı B., ÖZBEK SARICA P., Karademir Yılmaz B., et al.

Frontiers in Bioinformatics , cilt.1, 2021 (Hakemli Dergi) Sürdürülebilir Kalkınma

40. Overview of omics biomarkers in pituitary neuroendocrine tumors to design future diagnosis and treatment strategies

Aydin B., Caliskan A., ARĞA K. Y.

EPMA JOURNAL , cilt.12, sa.3, ss.383-401, 2021 (SCI-Expanded)

41. Differential Protein Interactome in Esophageal Squamous Cell Carcinoma Offers Novel Systems Biomarker Candidates with High Diagnostic and Prognostic Performance

Gulfidan G., Beklen H., Sinha I., Kucukalp F., Caloglu B., Esen I., et al.

OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY , cilt.25, ss.495-512, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma

42. Thanatechnology and the Living Dead: New Concepts in Digital Transformation and Human-Computer Interaction

Ozdemir V., Springer S., YILDIRIM A., Bicer S., Kendirci A., Sardas S., et al.

OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY , cilt.25, ss.401-407, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma

43. Systems-level biomarkers identification and drug repositioning in colorectal cancer

Beklen H., Yildirim E., Kori M., TURANLI B., ARĞA K. Y.

WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY , cilt.13, sa.7, ss.638-661, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma

44. Monogenic Childhood Diabetes: Dissecting Clinical Heterogeneity by Next-Generation Sequencing in Maturity-Onset Diabetes of the Young

Demirci D. K., Darendeliler F., Poyrazoglu S., Al A. D. K., GÜL N., Tutuncu Y., et al.

OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY , cilt.25, ss.431-449, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma

45. Cancer Stem Cell Transcriptome Profiling Reveals Seed Genes of Tumorigenesis: New Avenues for Cancer Precision Medicine

Comertpay B., Gulfidan G., ARĞA K. Y., Gov E.

OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY , cilt.25, ss.372-388, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma

46. Recent Developments in Cancer Systems Biology: Lessons Learned and Future Directions

ARĞA K. Y., Sinha R.

JOURNAL OF PERSONALIZED MEDICINE , cilt.11, sa.4, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma

47. Unexpectedly lower mortality rates in COVID-19 patients with and without type 2 diabetes in Istanbul

Satman I., Demirci I., Haymana C., Tasci I., Salman S., Ata N., et al.

DIABETES RESEARCH AND CLINICAL PRACTICE , cilt.174, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma

48. The Repertoire of Glycan Alterations and Glycoproteins in Human Cancers.

Kori M., Aydin B., Gulfidan G., Beklen H., Kelesoglu N., Caliskan Iscan A., et al.

Omics : a journal of integrative biology , cilt.25, sa.3, ss.139-168, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma

49. Current State of "Omics" Biomarkers in Pancreatic Cancer

TURANLI B., Yildirim E., Gulfidan G., ARĞA K. Y., Sinha R.

JOURNAL OF PERSONALIZED MEDICINE , cilt.11, sa.2, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma

50. ETS-Domain Transcription Factor Elk-1 Regulates Stemness Genes in Brain Tumors and CD133+ BrainTumor-Initiating Cells

SÖĞÜT M. S., Venugopal C., KANDEMİR B., Dag U., Mahendram S., Singh S., et al.

JOURNAL OF PERSONALIZED MEDICINE , cilt.11, sa.2, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma

51. Differential Interactome Proposes Subtype-Specific Biomarkers and Potential Therapeutics in Renal Cell Carcinomas

Caliskan A., Gulfidan G., Sinha R., ARĞA K. Y.

JOURNAL OF PERSONALIZED MEDICINE , cilt.11, sa.2, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma

52. Systems biology based drug repositioning for development of cancer therapy.

Turanli B., Altay O., Borén J., Turkez H., Nielsen J., Uhlen M., et al.

Seminars in cancer biology , cilt.68, ss.47-58, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma

53. Integrative transcriptomics analysis of lung epithelial cells and identification of repurposable drug candidates for COVID-19

Islam T., Rahman M. R., Aydin B., Beklen H., ARĞA K. Y., Shahjaman M.

EUROPEAN JOURNAL OF PHARMACOLOGY , cilt.887, 2020 (SCI-Expanded) Sürdürülebilir Kalkınma

54. Comprehensive Analysis of RNA-Seq Gene Expression Profiling of Brain Transcriptomes Reveals Novel Genes, Regulators, and Pathways in Autism Spectrum Disorder

Rahman M. R., Petralia M. C., Ciurleo R., Bramanti A., Fagone P., Shahjaman M., et al.

BRAIN SCIENCES , cilt.10, sa.10, 2020 (SCI-Expanded)

55. Transcriptomic profile of Pea3 family members reveal regulatory codes for axon outgrowth and neuronal connection specificity

KANDEMİR B., Gulfidan G., ARĞA K. Y., YILMAZ B., KURNAZ I.

SCIENTIFIC REPORTS , cilt.10, sa.1, 2020 (SCI-Expanded)

56. Pathways involved in viral oncogenesis: New perspectives from virus-host protein interactomics

Caliskan A., Andac A. C., ARĞA K. Y.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE , cilt.1866, sa.10, 2020 (SCI-Expanded) Sürdürülebilir Kalkınma

57. Novel molecular signatures and potential therapeutics in renal cell carcinomas: Insights from a comparative analysis of subtypes

GENOMICS , cilt.112, sa.5, ss.3166-3178, 2020 (SCI-Expanded) Sürdürülebilir Kalkınma

58. COVID-19 and the Futures of Machine Learning

Aydin B., ARĞA K. Y., KARADAĞ A. S.

OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY , cilt.24, sa.9, ss.512-514, 2020 (SCI-Expanded) Sürdürülebilir Kalkınma

59. Drug Repositioning for P-Glycoprotein Mediated Co-Expression Networks in Colorectal Cancer

Beklen H., Gulfidan G., ARĞA K. Y., Mardinoglu A., Turanli B.

FRONTIERS IN ONCOLOGY , cilt.10, 2020 (SCI-Expanded) Sürdürülebilir Kalkınma

60. Higher proteotoxic stress rather than mitochondrial damage is involved in higher neurotoxicity of bortezomib compared to carfilzomib

Jannuzzi A., Arslan S., Yilmaz A. M., Sari G., Beklen H., Méndez L., et al.

REDOX BIOLOGY , cilt.32, 2020 (SCI-Expanded)

61. New Machine Learning Applications to Accelerate Personalized Medicine in Breast Cancer: Rise of the Support Vector Machines

Ozer M. E., Sarica P., ARĞA K. Y.

OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY , cilt.24, sa.5, ss.241-246, 2020 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

62. Mapping the Molecular Basis and Markers of Papillary Thyroid Carcinoma Progression and Metastasis Using Global Transcriptome and microRNA Profiling.

Akyay O., Gov E., Kenar H., Arga K. Y., Selek A., Tarkun İ., et al.

Omics : a journal of integrative biology , cilt.24, ss.148-159, 2020 (SCI-Expanded)

63. Pan-cancer mapping of differential protein-protein interactions

Gulfidan G., Turanli B., Beklen H., Sinha R., Arga K. Y.

SCIENTIFIC REPORTS , cilt.10, sa.1, 2020 (SCI-Expanded) Sürdürülebilir Kalkınma

64. Digging Deeper into Precision/Personalized Medicine: Cracking the Sugar Code, the Third Alphabet of Life, and Sociomateriality of the Cell.

Özdemir V., Arga K. Y., Aziz R., Bayram M., Conley S., Dandara C., et al.

Omics : a journal of integrative biology , cilt.24, ss.62-80, 2020 (SCI-Expanded)

65. Omics-Driven Biomarkers of Psoriasis: Recent Insights, Current Challenges, and Future Prospects

CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY , cilt.13, ss.611-625, 2020 (SCI-Expanded)

66. Interview with Prof. K. Yalçın Arga: A Pioneer of Multi-Omics Science and Health Care Innovation.

Arga K. Y.

Omics : a journal of integrative biology , cilt.23, ss.460-462, 2019 (SCI-Expanded)

67. Cancer Drug Repositioning by Comparison of Gene Expression in Humans and Axolotl (<i>Ambystoma mexicanum</i>) During Wound Healing.

Öktem E., Yazar M., Gulfidan G., Arga K. Y.

Omics : a journal of integrative biology , cilt.23, ss.389-405, 2019 (SCI-Expanded) Sürdürülebilir Kalkınma

68. Co-expression Network Analysis Elucidated a Core Module in Association With Prognosis of Non-functioning Non-invasive Human Pituitary Adenoma.

Aydin B., Arga K. Y.

Frontiers in endocrinology , cilt.10, ss.361, 2019 (SCI-Expanded)

69. Novel Genomic Biomarker Candidates for Cervical Cancer As Identified by Differential Co-Expression Network Analysis.

Kori M., Gov E., Arga K. Y.

Omics : a journal of integrative biology , cilt.23, ss.261-273, 2019 (SCI-Expanded) Sürdürülebilir Kalkınma

70. Multi-Omic Data Interpretation to Repurpose Subtype Specific Drug Candidates for Breast Cancer

Turanli B., Karagoz K., Bidkhori G., Sinha R., Gatza M., Uhlen M., et al.

FRONTIERS IN GENETICS , cilt.10, 2019 (SCI-Expanded) Sürdürülebilir Kalkınma

71. Identification of Novel Components of Target-of-Rapamycin Signaling Pathway by Network-Based Multi-Omics Integrative Analysis

Eke E. D., ARĞA K. Y., Dikicioglu D., Eraslan S., Erkol E., ÇELİK FUSS A., et al.

OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY , cilt.23, sa.5, ss.274-284, 2019 (SCI-Expanded) Sürdürülebilir Kalkınma

72. Discovery of therapeutic agents for prostate cancer using genome-scale metabolic modeling and drug repositioning

Turanli B., Zhang C., Kim W., Benfeitas R., Uhlen M., Arga K. Y., et al.

EBIOMEDICINE , cilt.42, ss.386-396, 2019 (SCI-Expanded) Sürdürülebilir Kalkınma

73. Network-based approach to identify molecular signatures and therapeutic agents in Alzheimer's disease

Rahman M. R., Islam T., TURANLI B., Zaman T., Faruquee H. M., Rahman M. M., et al.

COMPUTATIONAL BIOLOGY AND CHEMISTRY , cilt.78, ss.431-439, 2019 (SCI-Expanded)

74. Identification of Prognostic Biomarker Signatures and Candidate Drugs in Colorectal Cancer: Insights from Systems Biology Analysis

Rahman M. R., Islam T., Gov E., Turanli B., Gulfidan G., Shahjaman M., et al.

MEDICINA-LITHUANIA , cilt.55, sa.1, 2019 (SCI-Expanded) Sürdürülebilir Kalkınma

75. Potential biomarkers and therapeutic targets in cervical cancer: Insights from the meta-analysis of transcriptomics data within network biomedicine perspective

PLOS ONE , cilt.13, sa.7, 2018 (SCI-Expanded) Sürdürülebilir Kalkınma

76. Exopolysaccharides Synthesized by Thermophilic MicroorganismsIsolated from Bulgarian Hot Springs

KAMBOUROVA M., RADCHENKOVA N., NICOLAUS B., TOMMONARO G., POLI A., TOKSOY ÖNER E., et al.

Acta Microbiologica Bulgarica , cilt.34, ss.68-76, 2018 (Scopus)

77. Drug Targeting and Biomarkers in Head and Neck Cancers: Insights from Systems Biology Analyses

İSLAM T., RAHMAN R., GÖV E., TURANLI B., GÜLFİDAN G., HAQUE M. A., et al.

OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY , cilt.22, sa.6, ss.422-436, 2018 (SCI-Expanded) Sürdürülebilir Kalkınma

78. Drug Repositioning for Effective Prostate Cancer Treatment

TURANLI B., Grotli M., BOREN J., NIELSEN J., UHLEN M., ARĞA K. Y., et al.

FRONTIERS IN PHYSIOLOGY , cilt.9, 2018 (SCI-Expanded) Sürdürülebilir Kalkınma

79. Systems biomarkers in psoriasis: Integrative evaluation of computational and experimental data at transcript and protein levels

Sevimoglu T., Turanli B., Bereketoglu C., ARĞA K. Y., KARADAĞ A. S.

GENE , cilt.647, ss.157-163, 2018 (SCI-Expanded) Sürdürülebilir Kalkınma

80. The Genome-Based Metabolic Systems Engineering to Boost Levan Production in a Halophilic Bacterial Model

Aydin B., Ozer T., Oner E. T., ARĞA K. Y.

OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY , cilt.22, sa.3, ss.198-209, 2018 (SCI-Expanded) Sürdürülebilir Kalkınma

81. A Network-Based Cancer Drug Discovery: From Integrated Multi-Omics Approaches to Precision Medicine

TURANLI B., Karagoz K., Gulfidan G., Sinha R., Mardinoglu A., ARĞA K. Y.

CURRENT PHARMACEUTICAL DESIGN , cilt.24, sa.32, ss.3778-3790, 2018 (SCI-Expanded) Sürdürülebilir Kalkınma

82. Genome reprogramming in Saccharomyces cerevisiae upon nonylphenol exposure

Bereketoglu C., ARĞA K. Y., Eraslan S., MERTOĞLU B.

PHYSIOLOGICAL GENOMICS , cilt.49, sa.10, ss.549-566, 2017 (SCI-Expanded) Sürdürülebilir Kalkınma

83. Transcriptomic-Guided Drug Repositioning Supported by a New Bioinformatics Search Tool: geneXpharma

Turanli B., Gulfidan G., ARĞA K. Y.

OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY , cilt.21, sa.10, ss.584-591, 2017 (SCI-Expanded) Sürdürülebilir Kalkınma

84. Multiomics Analysis of Tumor Microenvironment Reveals Gata2 and miRNA-124-3p as Potential Novel Biomarkers in Ovarian Cancer

Gov E., Kori M., ARĞA K. Y.

OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY , cilt.21, sa.10, ss.603-615, 2017 (SCI-Expanded) Sürdürülebilir Kalkınma

85. Systems Biomedicine Acts as a Driver for the Evolution of Pharmacology

TURANLI B., ARĞA K. Y.

Annals of Pharmacology and Pharmaceutics , cilt.2, ss.1087-1088, 2017 (Hakemli Dergi)

86. Transcriptomic analysis displays the effect of (-)-roemerine on the motility and nutrient uptake in Escherichia coli

Ayyildiz D., ARĞA K. Y., Avci F. G., ALTINIŞIK KAYA F. E., Gurer C., Toplan G. G., et al.

CURRENT GENETICS , cilt.63, sa.4, ss.709-722, 2017 (SCI-Expanded) Sürdürülebilir Kalkınma

87. Differential co-expression analysis reveals a novel prognostic gene module in ovarian cancer

Dayan I. E., ARĞA K. Y., Ulgen K. O.

SCIENTIFIC REPORTS , cilt.7, 2017 (SCI-Expanded) Sürdürülebilir Kalkınma

88. Hypothesis: Are There Molecular Signatures of Yoga Practice in Peripheral Blood Mononuclear Cells?

Ayyildiz D., ARĞA K. Y.

OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY , cilt.21, sa.7, ss.426-428, 2017 (SCI-Expanded)

89. Ovarian Cancer Differential Interactome and Network Entropy Analysis Reveal New Candidate Biomarkers

Ayyildiz D., Gov E., Sinha R., ARĞA K. Y.

OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY , cilt.21, sa.5, ss.285-294, 2017 (SCI-Expanded) Sürdürülebilir Kalkınma

90. Analysis of transcriptional profiles of Saccharomyces cerevisiae exposed to bisphenol A

Bereketoglu C., ARĞA K. Y., Eraslan S., MERTOĞLU B.

CURRENT GENETICS , cilt.63, sa.2, ss.253-274, 2017 (SCI-Expanded)

91. Multiomics Approach to Novel Therapeutic Targets for Cancer and Aging-Related Diseases: Role of Sld7 in Yeast Aging Network

OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY , cilt.21, sa.2, ss.100-113, 2017 (SCI-Expanded) Sürdürülebilir Kalkınma

92. RNA-based ovarian cancer research from 'a gene to systems biomedicine' perspective

Gov E., Kori M., ARĞA K. Y.

SYSTEMS BIOLOGY IN REPRODUCTIVE MEDICINE , cilt.63, sa.4, ss.219-238, 2017 (SCI-Expanded) Sürdürülebilir Kalkınma

93. Interactive cooperation and hierarchical operation of microRNA and transcription factor crosstalk in human transcriptional regulatory network

Karagoz K., Sevimoglu T., ARĞA K. Y.

IET SYSTEMS BIOLOGY , cilt.10, sa.6, ss.219-228, 2016 (SCI-Expanded) Sürdürülebilir Kalkınma

94. Metabolic Biomarkers and Neurodegeneration: A Pathway Enrichment Analysis of Alzheimer's Disease, Parkinson's Disease, and Amyotrophic Lateral Sclerosis

Kori M., Aydin B., ÜNAL S., ARĞA K. Y., KAZAN D.

OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY , cilt.20, sa.11, ss.645-661, 2016 (SCI-Expanded)

95. Integration of multiple biological features yields high confidence human protein interactome

JOURNAL OF THEORETICAL BIOLOGY , cilt.403, ss.85-96, 2016 (SCI-Expanded) Sürdürülebilir Kalkınma

96. Molecular signatures of ovarian diseases: Insights from network medicine perspective

Kori M., Gov E., ARĞA K. Y.

SYSTEMS BIOLOGY IN REPRODUCTIVE MEDICINE , cilt.62, sa.4, ss.266-282, 2016 (SCI-Expanded) Sürdürülebilir Kalkınma

97. Systems biology perspective on diabetic nephropathy may reveal molecular mechanism of diabetic retinopathy

Calimlioglu B., Ozturk R., Arga K.

NEW BIOTECHNOLOGY , cilt.33, 2016 (SCI-Expanded) Sürdürülebilir Kalkınma

98. Investigating the toxic effects of nonylphenol on Saccharomyces cerevisiae

Bereketoglu C., ARĞA K. Y., MERTOĞLU B.

NEW BIOTECHNOLOGY , cilt.33, 2016 (SCI-Expanded)

99. "Omics" of Selenium Biology: A Prospective Study of Plasma Proteome Network Before and After Selenized-Yeast Supplementation in Healthy Men

Sinha I., Karagoz K., Fogle R. L., Hollenbeak C. S., Zea A. H., ARĞA K. Y., et al.

OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY , cilt.20, sa.4, ss.202-213, 2016 (SCI-Expanded) Sürdürülebilir Kalkınma

100. Proteomic and Metabolic Signatures of Esophageal Squamous Cell Carcinoma

KARAGÖZ K., LEHMAN H. L., STAİRS D. B., SİNHA R., ARĞA K. Y.

CURRENT CANCER DRUG TARGETS , cilt.16, sa.8, ss.721-736, 2016 (SCI-Expanded) Sürdürülebilir Kalkınma

101. Cardiomyogenic differentiation potential of human lipoaspirate-derived stem cells on hyaluronic acid/gelatin plasma gels

GÖV E., KENAR H., HALBUTOĞULLARI Z. S., ARĞA K. Y., KARAÖZ E.

TURKISH JOURNAL OF BIOLOGY , cilt.40, sa.2, ss.369-379, 2016 (SCI-Expanded)

102. Computational Systems Biology of Psoriasis: Are We Ready for the Age of Omics and Systems Biomarkers?

Sevimoglu T., ARĞA K. Y.

OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY , cilt.19, sa.11, ss.669-687, 2015 (SCI-Expanded) Sürdürülebilir Kalkınma

103. Tissue-Specific Molecular Biomarker Signatures of Type 2 Diabetes: An Integrative Analysis of Transcriptomics and Protein-Protein Interaction Data

Calimlioglu B., Karagoz K., Sevimoglu T., Kilic E., Gov E., ARĞA K. Y.

OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY , cilt.19, sa.9, ss.563-573, 2015 (SCI-Expanded) Sürdürülebilir Kalkınma

104. Genomic analysis reveals the biotechnological and industrial potential of levan producing halophilic extremophile, Halomonas smyrnensis AAD6T

Diken E., Ozer T., Arikan M., Emrence Z., Oner E. T., ÜSTEK D., et al.

SPRINGERPLUS , cilt.4, 2015 (SCI-Expanded)

105. Effective stimulating factors for microbial levan production by Halomonas smyrnensis AAD6(T)

Sarilmiser H. K., Ates O., Ozdemir G., ARĞA K. Y., Oner E. T.

JOURNAL OF BIOSCIENCE AND BIOENGINEERING , cilt.119, sa.4, ss.455-463, 2015 (SCI-Expanded)

106. Genomic analysis of Brevibacillus thermoruber 423 reveals its biotechnological and industrial potential

Yildiz S. Y., Radchenkova N., ARĞA K. Y., Kambourova M., Oner E. T.

APPLIED MICROBIOLOGY AND BIOTECHNOLOGY , cilt.99, sa.5, ss.2277-2289, 2015 (SCI-Expanded)

107. Triple Negative Breast Cancer: A Multi-Omics Network Discovery Strategy for Candidate Targets and Driving Pathways

Karagoz K., Sinha R., ARĞA K. Y.

OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY , cilt.19, sa.2, ss.115-130, 2015 (SCI-Expanded) Sürdürülebilir Kalkınma

108. GENETIC MUTATIONS ARE CHARACTERIZED BY INCREASE IN ENTROPY AT THE TRANSCRIPTIONAL LEVEL

JOURNAL OF BIOLOGICAL SYSTEMS , cilt.22, sa.3, 2014 (SCI-Expanded)

109. A system based network approach to ethanol tolerance in Saccharomyces cerevisiae

Kasavi C., Eraslan S., ARĞA K. Y., Oner E. T., KIRDAR B.

BMC SYSTEMS BIOLOGY , cilt.8, 2014 (SCI-Expanded)

110. The role of protein interaction networks in systems biomedicine

SEVİMOĞLU T., ARĞA K. Y.

Computational and Structural Biotechnology Journal , cilt.11, ss.22-27, 2014 (Scopus)

111. Computational prediction of associations between psoriasis, rheumatoid arthritis and osteoarthritis

Sevimoglu T., ARĞA K. Y.

NEW BIOTECHNOLOGY , cilt.31, 2014 (SCI-Expanded)

112. Systems biology solutions to challenges in marine biotechnology

Yildiz S. Y., Kambourova M., ARĞA K. Y., TOKSOY ÖNER E.

FRONTIERS IN MARINE SCIENCE , cilt.1, 2014 (SCI-Expanded)

113. Comparison of Protein Expression Profiles of Novel lt i gt Halomonas smyrnensis lt i gt AAD6 lt sup gt T lt sup gt and lt i gt Halomonas salina lt i gt DSMZ 5928 lt sup gt T lt sup gt

ARĞA K. Y., KAZAN D., Dilgimen A., Erdmann V., WittmannLiebold B., Denizci A. A.

Natural Science , cilt.6, ss.628-640, 2014 (Hakemli Dergi)

114. The Stimulatory Effect of Mannitol on Levan Biosynthesis: Lessons from Metabolic Systems Analysis of Halomonas smyrnensis AAD6(T)

Ates O., ARĞA K. Y., Oner E. T.

BIOTECHNOLOGY PROGRESS , cilt.29, sa.6, ss.1386-1397, 2013 (SCI-Expanded)

115. Draft Genome Sequence of Exopolysaccharide-Producing Thermophilic Bacterium Brevibacillus thermoruber Strain 423

MICROBIOLOGY RESOURCE ANNOUNCEMENTS , cilt.1, sa.5, 2013 (ESCI)

116. Assessment of high-confidence protein-protein interactome in yeast

Karagoz K., ARĞA K. Y.

COMPUTATIONAL BIOLOGY AND CHEMISTRY , cilt.45, ss.1-8, 2013 (SCI-Expanded)

117. Draft Genome Sequence of Halomonas smyrnensis AAD6(T)

Sogutcu E., Emrence Z., Arikan M., Cakiris A., Abaci N., Oner E. T., et al.

JOURNAL OF BACTERIOLOGY , cilt.194, sa.20, ss.5690-5691, 2012 (SCI-Expanded)

118. Identification of Exopolysaccharide Biosynthesis Mechanism of Halomonas smyrnensis AAD6(T)

Sogutcu E., Oner E. T., ARĞA K. Y.

NEW BIOTECHNOLOGY , cilt.29, 2012 (SCI-Expanded)

119. Identification of candidate genes related to ethanol tolerance in Saccharomyces cerevisiae via a systems based modular approach

Kasavi C., ARĞA K. Y., Oner E. T., KIRDAR B.

NEW BIOTECHNOLOGY , cilt.29, 2012 (SCI-Expanded)

120. Combining various heterogeneous biological features to obtain a highly reliable almost complete protein interaction network of yeast

Karagoz K., ARĞA K. Y.

NEW BIOTECHNOLOGY , cilt.29, 2012 (SCI-Expanded)

121. Genome-scale reconstruction of metabolic network for a halophilic extremophile, Chromohalobacter salexigens DSM 3043

ATEŞ Ö., Oner E., ARĞA K. Y.

BMC SYSTEMS BIOLOGY , cilt.5, 2011 (SCI-Expanded)

122. A cross-sectional study of biotechnology awareness and teaching in European high schools

Vanderschuren H., Heinzmann D., Faso C., Stupak M., ARĞA K. Y., Hoerzer H., et al.

NEW BIOTECHNOLOGY , cilt.27, sa.6, ss.822-828, 2010 (SCI-Expanded)

123. Genome-scale reconstruction of metabolic network for a halophilic extremophile, Chromohalobacter salexigens

Ates O., Oner E. T., Arga K. Y.

NEW BIOTECHNOLOGY , cilt.25, 2009 (SCI-Expanded)

124. Modeling of batch fermentation kinetics for levan production by Halomonas spp.

Kazak H., Arga K. Y., Oner E. T.

NEW BIOTECHNOLOGY , cilt.25, 2009 (SCI-Expanded)

125. Drug targets for tumorigenesis: Insights from structural analysis of EGFR signaling network

Tekir S. D., ARĞA K. Y., Uelgen K. O.

JOURNAL OF BIOMEDICAL INFORMATICS , cilt.42, sa.2, ss.228-236, 2009 (SCI-Expanded) Sürdürülebilir Kalkınma

126. A consensus yeast metabolic network reconstruction obtained from a community approach to systems biology

Herrgård M. J., Swainston N., Dobson P., Dunn W. B., ARĞA K. Y., Arvas M., et al.

NATURE BIOTECHNOLOGY , cilt.26, sa.10, ss.1155-1160, 2008 (SCI-Expanded)

127. DECIPHERING THE CROSS-TALK BETWEEN SPHINGOLIPID MECHANISM AND SIGNALING PATHWAYS IN BAKER'S YEAST

Yucel E., Cankorur A., Dereli E., Alazi F., Aslandag I., Kavun B., et al.

SIGMA JOURNAL OF ENGINEERING AND NATURAL SCIENCES-SIGMA MUHENDISLIK VE FEN BILIMLERI DERGISI , cilt.26, sa.3, ss.162-174, 2008 (ESCI)

128. Understanding signaling in yeast: Insights from network analysis

ARĞA K. Y., Oensan Z. I., Kirdar B., Uelgen K. O., Nielsen J.

BIOTECHNOLOGY AND BIOENGINEERING , cilt.97, sa.5, ss.1246-1258, 2007 (SCI-Expanded)

129. Flux analysis of recombinant Saccharomyces cerevisiae YPB-G utilizing starch for optimal ethanol production

Cakir T., ARĞA K. Y., Altintas M., Ulgen K.

PROCESS BIOCHEMISTRY , cilt.39, sa.12, ss.2097-2108, 2004 (SCI-Expanded)

130. Transfer function approach in structured modeling of recombinant yeast utilizing starch

ARĞA K. Y., Cakir T., Pir P., Ozer N., Altintas M., Ulgen K.

PROCESS BIOCHEMISTRY , cilt.39, sa.10, ss.1237-1248, 2004 (SCI-Expanded)

131. Flux analysis of the recombinant Saccharomyces cerevisiae YPB G utilizing starch for optimum ethanol production

ÇAKIR T., ARĞA K. Y., ALTINTAŞ M., ÜLGEN Ş. K.

Process Biochemistry , ss.2097-2108, 2004 (SCI-Expanded)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 73

1. Effect of Chemotherapy Drugs Combined with Flavonoid on Colorectal Cancer Cells

KANLI Z., AYDIN OMAY B., ERZİK C., ARĞA K. Y., CABADAK H.

International Marmara Sciences Congress, Kocaeli, Türkiye, 9 - 10 Aralık 2022, ss.41, (Özet Bildiri)

2. Flavonoid ile Kombine Edilmiş Kemoterapi İlaçlarının Kolorektal Kanser Hücrelerine Etkisi

Kanlı Z., Aydın Omay B., Erzik C., Arğa K. Y., Cabadak H.

9. ULUSLARARASI MARMARA FEN BİLİMLERİ KONGRESİ, Kocaeli, Türkiye, 9 - 10 Aralık 2022, ss.1-2, (Özet Bildiri) Sürdürülebilir Kalkınma

3. Transcriptomics-Based Drug Repurposing Unravels Novel Therapeutic Strategies in AML

KELEŞOĞLU N., Korkmaz N. S., TURANLI B., ARĞA K. Y., YILMAZ B., ATEŞ DURU Ö.

4th EURASIA BIOCHEMICAL APPROACHES & TECHNOLOGIES (EBAT) CONGRESS, Antalya, Türkiye, 3 - 06 Kasım 2022, (Özet Bildiri)

4. Differential Interactome Based Drug Repositioning Unraveled Potential Therapeutics for Colorectal Cancers

BEKLEN H., Arslan S., GULFİDAN G., TURANLI B., ÖZBEK SARICA P., YILMAZ B., et al.

3rd EURASIA BIOCHEMICAL APPROACHES & TECHNOLOGIES (EBAT) CONGRESS, Antalya, Türkiye, 4 - 07 Kasım 2021, (Özet Bildiri)

5. Novel Systems Biomarker Candidates with High Diagnostic and Prognostic Performance in Esophageal Squamous Cell Carcinoma

GULFİDAN G., BEKLEN H., TURANLI B., AYYILDIZ D., Sinha R., ARĞA K. Y.

3rd EURASIA BIOCHEMICAL APPROACHES & TECHNOLOGIES (EBAT) CONGRESS, Antalya, Türkiye, 4 - 07 Kasım 2021, (Özet Bildiri)

6. Decoding molecular signatures of pituitary neuroendocrine tumors’ subtypes through systems biomedicine perspective

AYDIN B., Yildirim Sirkeci E., ERDOĞAN O., BAYRAKLI F., BOZKURT S., ARĞA K. Y., et al.

5th International Symposium on Bioinformatics (InSyB2021), İstanbul, Türkiye, 15 - 17 Aralık 2021, (Özet Bildiri)

7. Drug Respositioning in Colorectal Cancer by using Co-expression Networks of P-glycoprotein

BEKLEN H., GÜLFİDAN G., ARĞA K. Y., NIELSEN J., TURANLI B.

13th The International Symposium on Health Informatics and Bioinformatics, Türkiye, 22 - 23 Ekim 2020, (Özet Bildiri) Sürdürülebilir Kalkınma

8. DRUG REPOSITIONING IN PROSTATE CANCER THROUGH GENOME-SCALE METABOLIC MODELING

AYDOĞMUŞ E. M., gülfidan g., TURANLI B., ERZİK C., DEMİR Ü., KISAAYAK ÇOLLAK F., et al.

applied bioinformatics in life sciences, Leuven, Belçika, 13 - 14 Şubat 2020 Sürdürülebilir Kalkınma

9. Determination Of Candidate Biomarkers Through Differential Interactome in Colorectal Adenocarcinoma

BEKLEN H., GULFİDAN G., TURANLI B., ÖZBEK SARICA P., YILMAZ B., ARĞA K. Y.

The 12th International Symposium on Health Informatics and Bioinformatics (HIBIT 2019), İzmir, Türkiye, 17 - 19 Ekim 2019, (Özet Bildiri)

10. Identification of Systems Biomarkers and Candidate Drugs in Prostate Adenocarcinoma

GULFİDAN G., BEKLEN H., TURANLI B., ARĞA K. Y.

The 12th International Symposium on Health Informatics and Bioinformatics (HIBIT 2019), İzmir, Türkiye, 17 - 19 Ekim 2019, (Özet Bildiri)

11. Drug repositioning for cancer therapy by the employment of systems biology

TURANLI B., GULFİDAN G., Mardinoğlu A., ARĞA K. Y.

Cell Death: Degeneration and Regeneration Symposium, İstanbul, Türkiye, 3 - 05 Ekim 2019, (Özet Bildiri)

12. Review of the Occupational Health and Safety in the Metal Sector in Turkey

ERGİN ESEN H., ARĞA K. Y.

8. International Vocational Schools Symposium, Sinop, Türkiye, 11 - 13 Haziran 2019, (Tam Metin Bildiri)

13. Systems Biomarkers for Accurate Diagnosis, Prognosis and Therapy in Neurological Disorders

Altınışık F. E., Arğa K. Y., Kazan D., Sarıyar Akbulut B.

FENS Regional Meeting, 10 - 13 Temmuz 2019, (Tam Metin Bildiri)

14. Understanding the metabolic reprogramming behind alkaliphilic adaptation in Bacillus marmarensis through a multi-omics data integration strategy

44th FEBS Congress: From molecules to living systems, Krakow, Polonya, 6 - 11 Temmuz 2019, (Özet Bildiri)

15. 112 Ambulans ve Acil Komuta Merkezi Çalışanlarında İş Sağlığı ve Güvenliği

IŞIK BARSAN Ö., ARĞA K. Y.

3rd INTERNATIONAL OCCUPATIONAL ANDENVIRONMENTAL DISEASES CONGRESS, 3 - 07 Mart 2019, (Tam Metin Bildiri)

16. Drug repositioning for the treatment of cervical cancer through host-pathogen protein-protein interactions

TURANLI B., Kori M., ARĞA K. Y.

6th International Bau Drug Design Congress, İstanbul, Türkiye, 13 - 15 Aralık 2018, (Özet Bildiri) Sürdürülebilir Kalkınma

17. Prostat kanserinin diferansiyel protein etkileşim ağı haritasındaki yeri.

Gulfidan G., TURANLI B., ARĞA K. Y.

19. Uluslararası Katılımlı Biyoteknoloji Kongresi, Eskişehir, Türkiye, 30 Kasım - 03 Aralık 2018, (Özet Bildiri) Sürdürülebilir Kalkınma

18. Systems Biomarkers in Cancer Diagnosis, Prognosis and Therapy

TURANLI B., GÜLFİDAN G., ARĞA K. Y.

2nd International Cell Death Research Congress, 1 - 04 Kasım 2018, (Özet Bildiri) Sürdürülebilir Kalkınma

19. Prostate cancer-specific metabolic model as a tool for drug repositioning

TURANLI B., LOVRIC A., RUI B., Bidkhori G., Zhang C., ARĞA K. Y., et al.

International Conference on Applied Mathematics, Modeling and Life Sciences, 3 - 05 Ekim 2018, (Özet Bildiri) Sürdürülebilir Kalkınma

20. Model driven discovery of drug targets for effective treatment of prostate cancer (Poster)

TURANLI B., Lovric A., Benfeitas R., Bidkhori G., Zhang C., ARĞA K. Y., et al.

Conference on Intelligent Systems for Molecular Biolog (ISMB2018), Chicago, Amerika Birleşik Devletleri, 6 - 10 Temmuz 2018, (Özet Bildiri) Sürdürülebilir Kalkınma

21. Model driven discovery of drug targets for effective treatment of prostate cancer

TURANLI B., Benfeitas R., Lovric A., Bidkhori G., Zhang C., ARĞA K. Y., et al.

Conference on Intelligent Systems for Molecular Biolog (ISMB2018), Chicago, Amerika Birleşik Devletleri, 6 - 10 Temmuz 2018, (Özet Bildiri) Sürdürülebilir Kalkınma

22. Comparative Analysis Of Human Cancers Through Molecular Signatures

Applied Bioinformatics in Life Sciences, Leuven, Belçika, 8 Mart - 09 Ağustos 2018, (Özet Bildiri) Sürdürülebilir Kalkınma

23. A metabolic network approach for the identification of drugs against prostate cancer

TURANLI B., Al Shobky M., Benfeitas R., Bidkhori G., Zhang C., ARĞA K. Y., et al.

Applied Bioinformatics in Life Sciences (2nd edition), Leuven, Belçika, 8 - 09 Mart 2018, (Özet Bildiri) Sürdürülebilir Kalkınma

24. Kanserlerin işaretçi moleküller yoluyla karşılaştırmalı analizi

TURANLI B., Gulfidan G., ARĞA K. Y.

III.Yaşam Bilimleri Kongresi, Kayseri, Türkiye, 23 - 24 Şubat 2018, (Özet Bildiri) Sürdürülebilir Kalkınma

25. Protein-protein interaction analysis of differentially expressed genes in head and neck cancer

İSLAM T., RAHMAN R., SHAHJAMAN M., HAQUE M. A., GÖV E., ARĞA K. Y., et al.

International Conference on Biotechnology in Health and Agriculture 2017, Dhaka, Bangladeş, 29 - 30 Aralık 2017, (Özet Bildiri) Sürdürülebilir Kalkınma

26. Integrated analysis of transcriptome and protein interactome in colorectal cancer

RAHMAN R., İSLAM T., SHAHJAMAN M., HAQUE M. A., ARĞA K. Y., MD NURUL HAQUE M.

International Conference on Biotechnology in Health and Agriculture 2017, Dhaka, Bangladeş, 29 - 30 Aralık 2017, (Özet Bildiri) Sürdürülebilir Kalkınma

27. Diferansiyel eş-anlatım analizi ile kansere yönelik teşhis ve tedavi amaçlı sistem biyobelirteçlerinin tayini

ERDÖL M. N., ARĞA K. Y.

19. Uluslararası Katılımlı Biyoteknoloji Kongresi, 1 - 03 Aralık 2017, (Özet Bildiri) Sürdürülebilir Kalkınma

28. Biyoinformatik: Temel kavramlar ve klinik uygulamaları

Klinisyenler için Moleküler Biyoloji ve Genetik Temel Kavramlar, İstanbul, Türkiye, 25 Kasım 2017, (Tam Metin Bildiri)

29. Transkriptom: Temel kavramlar ve klinik uygulamaları

GÜLFİDAN G., TURANLI B., ARĞA K. Y.

Klinisyenler için Moleküler Biyoloji ve Genetik Temel Kavramlar Sempozyumu, İstanbul, Türkiye, 25 Kasım 2017, (Tam Metin Bildiri)

30. Comprehensive mapping of differential protein interactome in human cancers

Uluslararası Katılımlı XV. Tıbbi Biyoloji ve Genetik Kongresi, 26 - 29 Ekim 2017, (Özet Bildiri) Sürdürülebilir Kalkınma

31. Transcriptome based systems biomarkers: a novel prognostic gene module in ovarian cancer

ARĞA K. Y., GÖV E.

Uluslararası Katılımlı XV. Tıbbi Biyoloji ve Genetik Kongresi, 26 - 29 Ekim 2017, (Özet Bildiri) Sürdürülebilir Kalkınma

32. Using Systems Based Models to Uncover the Disease Network of Psoriasis and its associations with other autoimmune-related diseases

SEVİMOĞLU T., ARĞA K. Y., KARADAĞ A. S.

26th European Academy of Dermatology and Venereology Congress, 13 - 17 Eylül 2017, (Özet Bildiri)

33. Tissue specific reporter biomolecules in ovarian cancer: novel biomarkers and candidate therapeutic targets

GÖV E., KORİ M., ARĞA K. Y.

Sanko Üniversitesi Tıpta İnovasyon Buluşmaları-3, 11 - 13 Mayıs 2017, (Özet Bildiri) Sürdürülebilir Kalkınma

34. Drug target identification through context-specific protein interaction networks with minimum uncertainty

ÇALIŞKAN A., AYYILDIZ D., GÖV E., ARĞA K. Y.

Sanko Üniversitesi Tıpta İnovasyon Buluşmaları-3, 11 - 13 Mayıs 2017, (Özet Bildiri)

35. Gene Expression Oriented Drug Repositoning Targets For Prostate Cancer

TURANLI B., GÜLFİDAN G., ARĞA K. Y.

Sanko Üniversitesi Tıpta İnovasyon Buluşmaları-3, 11 - 13 Mayıs 2017, (Özet Bildiri) Sürdürülebilir Kalkınma

36. A novel in silico methodology for drug target identification based on differential interactome

GÜLFİDAN G., TURANLI B., ARĞA K. Y.

Sanko Üniversitesi Tıpta İnovasyon Buluşmaları-3, 11 - 13 Mayıs 2017, (Özet Bildiri)

37. Pea3 transkripsiyon faktörünün nöronlardaki fonksiyonuyla ilişkili yeni hedeflerin belirlenmesi

KANDEMİR B., ARĞA K. Y., YILMAZ B., KURNAZ I.

15. Ulusal sinirbilim kongresi- Uluslararası Katılımlı, 7 - 10 Mayıs 2017, (Özet Bildiri)

38. The High Potential of Network Entropy Based Differential Protein Interactome Analysis for Diagnostics Innovation in Oncology and Tumor Pathogenesis: A Case Study on Ovarian Cancer

GÖV E., AYYILDIZ D., ARĞA K. Y.

International DNA Day And Genome Congress, 24 - 28 Nisan 2017, (Özet Bildiri) Sürdürülebilir Kalkınma

39. Genexpharma: Search Tool For Gene Expression Oriented Drug Repositoning

TURANLI B., GÜLFİDAN G., ARĞA K. Y.

International DNA Day And Genome Congress, 24 - 28 Nisan 2017, (Özet Bildiri)

40. Differential coexpression network in ovarian cancer Prognostic and therapeutic targets

GÖV E., ARĞA K. Y.

6. Multidisipliner Kanser Araştırma Kongresi, 27 - 30 Ekim 2016, (Özet Bildiri) Sürdürülebilir Kalkınma

41. Computational anti cancer agent repurposing for pancreatic cancer

ÇALIMLIOĞLU B., GÜLFİDAN G., ÖZTÜRK R., NALBANT Z., ARĞA K. Y.

6. Multidisipliner Kanser Araştırma Kongresi, 27 - 30 Ekim 2016, (Özet Bildiri) Sürdürülebilir Kalkınma

42. Roemerine limits carbohydrate uptake which leads to alternative nutrients such as acetyl coA sources

AYYILDIZ D., AVCI F. G., ARĞA K. Y., SARIYAR AKBULUT B.

FEBS 2016 Congress, 3 - 08 Eylül 2016, (Özet Bildiri)

43. Drug repositioning strategies aplied on a group of cancer

ÇALIMLIOĞLU B., GÜLFİDAN G., ÖZTÜRK R., NALBANT Z., ARĞA K. Y.

41. FEBS CONGRESS, 3 - 08 Eylül 2016, (Özet Bildiri) Sürdürülebilir Kalkınma

44. A glance at smoking effect on preeclamptic placenta with transcriptional regulation approach

Aydin B., Arga K. Y.

41st FEBS Congress on Molecular and Systems Biology for a Better Life, Kusadasi, Türkiye, 3 - 08 Eylül 2016, cilt.283, ss.77, (Özet Bildiri)

45. Drug repositioning strategies applied on a group of cancer

Calimlioglu B., Ozturk R., Nalbant Z., Gulfidan G., Arga K. Y.

41st FEBS Congress on Molecular and Systems Biology for a Better Life, Kusadasi, Türkiye, 3 - 08 Eylül 2016, cilt.283, ss.140, (Özet Bildiri) Sürdürülebilir Kalkınma

46. (-)-Roemerine limits carbohydrate uptake which leads to alternative nutrients as acetyl-CoA sources

Ayyildiz D., Avci F. G., Arga K. Y., Akbulut B. S.

41st FEBS Congress on Molecular and Systems Biology for a Better Life, Kusadasi, Türkiye, 3 - 08 Eylül 2016, cilt.283, ss.121-122, (Özet Bildiri)

47. Resemblance of human cancer stem cells based on genome-wide expression profiles

Gov E., Kaya N., Arga K. Y.

41st FEBS Congress on Molecular and Systems Biology for a Better Life, Kusadasi, Türkiye, 3 - 08 Eylül 2016, cilt.283, ss.300, (Özet Bildiri) Sürdürülebilir Kalkınma

48. Investigating the toxic effects of nonylphenol on Saccharomyces cerevisiae

17th European Congress on Biotechnology, 3 - 06 Temmuz 2016, (Özet Bildiri)

49. Investigating the toxic effects of nonylphenol on Saccharomyces cerevisae

ÇALIMLIOĞLU B., ÖZTÜRK R., ARĞA K. Y.

17th European Congress on Biotechnology, 3 - 06 Temmuz 2016

50. Systems biology perspective on diabetic nephropathy may reveal molecular mechanism of diabetic retinopathy

ECB2016 17. European Congress on Biotechnology, 3 - 06 Temmuz 2016, (Özet Bildiri) Sürdürülebilir Kalkınma

51. Investigating the toxic effects of nonylphenol on Saccharomyces cerevisiae

AYYILDIZ D., AVCI F. G., ARĞA K. Y., SARIYAR AKBULUT B.

ECB2016 - 17. European Congress on Biotechnology, 3 - 06 Temmuz 2016, (Özet Bildiri)

52. Transcriptional analysis of nonylphenol on Saccharomyces cerevisiae using DNA microarray

BEREKETOĞLU C., ARĞA K. Y., eraslan s., MERTOĞLU B.

EMBO Conference "Gene transcription in yeast: From chromatin to RNA and back", 11 - 16 Haziran 2016

53. Transcriptional analysis of nonylphenol on Saccharomyces cerevisiae using DNA microarray

BEREKETOĞLU C., ARĞA K. Y., Eraslan S., MERTOĞLU B.

Gene transcription in yeast: From chromatin to RNA and back, 11 - 16 Haziran 2016, (Özet Bildiri)

54. Transcriptional analysis of nonylphenol on Saccharomyces cerevisiae using DNA microarray

BEREKETOĞLU C., ARĞA K. Y., ERASLAN S., MERTOĞLU B.

Gene transcription in yeast: From chromatin to RNA and back, 11 - 16 Haziran 2016

55. Roemerine limits carbohydrate uptake which leads to alternative nutrients as acetly CoA sources

THE 41TH FEBS, 3 Eylül - 08 Haziran 2016

56. Integrant roles of microRNAs and transcription factors in ovarian cancer transcriptional regulatory network

GÖV E., ARĞA K. Y.

Innovation in Medicine Summit-2, 5 - 07 Mayıs 2016, (Özet Bildiri) Sürdürülebilir Kalkınma

57. The plant derived alkaloid roemerin is involved in the modulation of motility in E coli

AYYILDIZ D., AVCI F. G., ARĞA K. Y., BÜDEYRİ GÖKGÖZ N., SAYAR N. A., KAZAN D., et al.

BIOPHYSICAL SOCIETY 60TH ANNUAL MEETING, 27 Şubat - 02 Mart 2016

58. Multi Omic Stratejiler Yardımıyla Endometriyozis Hastalığı için Biyobelirteç Tayini

Kori M., ÇALIMLIOĞLU B., ARĞA K. Y.

4. Ulusal Moleküler Biyoloji ve Biyoteknoloji, Türkiye, 21 - 24 Ağustos 2015, (Özet Bildiri)

59. Sistem biyotıp araştırmaları için bütünleştirilmiş biyolojik ağlar yaklaşımı

ÇALIMLIOĞLU B., ARĞA K. Y.

4. ULUSAL MOLEKÜLER BİYOLOJİ VE BİYOTEKNOLOJİ KONGRESİ, Türkiye, 21 - 24 Ağustos 2015, (Özet Bildiri)

60. Transcriptomics Reveals Association Between Psoriasis and Rheumatoid Arthritis

SEVİMOĞLU T., ARĞA K. Y.

EuroMedLab Paris2015, Paris, Fransa, 21 - 25 Haziran 2015, (Özet Bildiri)

61. Genomic and Proteomic Candidate Biomarker Investigation for Personalized Medicine

Baran B., AKBAS M., ÇALIMLIOĞLU B., ARĞA K. Y.

3rd International Gen-Arel Molecular Biology and Genetics Student Congress, 24 - 25 Nisan 2015

62. Metabolic Variability Analysis Through Human Metabolic Model

ISLER E., Yavuz U., ÇALIMLIOĞLU B., ARĞA K. Y.

3rd International Gen-Arel Molecular Biology and Genetics Student Congress, 24 - 25 Nisan 2015

63. Computational association of autoimmune diseases: a case study

Sevimoglu T., Arga K. Y.

FEBS EMBO 2014 Conference, Paris, Fransa, 30 Ağustos - 04 Eylül 2014, cilt.281, ss.109-110, (Özet Bildiri)

64. Deciphering triple negative breast cancer driven pathways via multi-omic networks

Karagoz K., Sinha R., Arga K. Y.

FEBS EMBO 2014 Conference, Paris, Fransa, 30 Ağustos - 04 Eylül 2014, cilt.281, ss.452, (Özet Bildiri) Sürdürülebilir Kalkınma

65. Uncovering the interconnectivity between infertility-associated woman diseases

Kori M., Arga K. Y.

FEBS EMBO 2014 Conference, Paris, Fransa, 30 Ağustos - 04 Eylül 2014, cilt.281, ss.276, (Özet Bildiri)

66. Research on the action mechanisms of endocrine disrupting chemicals via system biology approach